Hemobilia Caused by Cytomegalovirus Cholangiopathy

Prasad, Ganapathy A.; Abraham, Susan C.; Baron, Todd H.; Topazian, Mark D.
November 2005
American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2592
Academic Journal
A 57-yr-old male on long-term steroid therapy presented with hematemesis, fever, and a retroperitoneal fluid collection. Hemobilia was diagnosed, but the cause was not identified by ERCP, computed tomography, or angiography. Peroral cholangioscopy revealed multiple biliary ulcers. Cholangioscopic biopsies diagnosed cytomegalovirus (CMV) infection. Intravenous ganciclovir therapy was initiated, and was associated with cessation of bleeding. Biliary CMV disease is rare in HIV-negative persons, but should be considered in a patient with unexplained hemobilia. Cholangioscopy may be useful for diagnosis.


Related Articles

  • Ganciclovir--Have We Established Clinical Value in the Treatment of Cytomegalovirus Infections? Whitley, Richard J. // Annals of Internal Medicine;Mar88, Vol. 108 Issue 3, p452 

    Editorial. Focuses on ganciclovir therapy for cytomegalovirus chorioretinitis in immunocompromised patients. Characteristics of cytomegalovirus; Occurrence of cytomegalovirus infection; Usefulness of ganciclovir for patients with cytomegalovirus infections.

  • Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT. Machado, C M; Menezes, R X; Macedo, M C A; Mendes, A V A; Vilas Boas, L S; Castelli, J B; Dulley, F L; Pannuti, C S // Bone Marrow Transplantation;12/1/2001, Vol. 28 Issue 11, p1053 

    Late CMV disease remains a major concern in allogeneic BMT recipients. Few surveillance data are available on the occurrence of CMV infection and recurrences after day +100. We evaluated the occurrence of antigenemia (AG) recurrences until day +365 in 76 patients who received pre-emptive...

  • Ganciclovir capsules plus implant improve CMV outcome. Scerra, Chet // Ophthalmology Times;08/15/98, Vol. 23 Issue 16, p46 

    Reports that oral ganciclovir combined with a ganciclovir implant seem to offer unilateral cytomegalovirus (CMV) retinitis patients a better prognosis. Comparison with the implant by itself or intravenous ganciclovir; Results of a trial; Reduction in the risk for Kaposi's sarcoma; Occurrence of...

  • A Neonate with Reduced Cytomegalovirus DNA Copy Number and Marked Improvement of Hearing in the Treatment of Congenital Cytomegalovirus Infection. Hayakawa, Jun; Kawakami, Yasuhiko; Takeda, Sachiyo; Ozawa, Hiroshi; Fukazawa, Ryuji; Takase, Masato; Fukunaga, Yoshitaka // Journal of Nippon Medical School;2012, Vol. 79 Issue 6, p471 

    Congenital cytomegalovirus (CMV) infection can cause severe permanent disabilities. A mother who is seronegative before conception but acquires infection during pregnancy is a risk factor for congenital infection. We describe a neonate in whom congenital CMV infection was diagnosed at birth and...

  • Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics. Filler, Guido; Lampe, Dagmar; von Bredow, Moritz A.; Lappenberg-Pelzer, Marianne; Rocher, Sonja; Strehlau, Jürgen; Ehrich, Jochen H. H. // Pediatric Nephrology;1998, Vol. 12 Issue 1, p6 

    Ganciclovir alone or in combination with hyperimmunoglobulin is replacing other treatment modalities for the prophylactic treatment of cytomegalovirus (CMV) infections. No dose recommendations are available for oral ganciclovir therapy in children with impaired renal function after renal...

  • Valganciclovir for congenital cytomegalovirus.  // Africa Health;Jul2015, Vol. 37 Issue 5, p37 

    The article examines the effect of intravenous ganciclovir as treatment in patients with symptomatic congenital cytomegalovirus (CMV) infection, a common cause of mental retardation and hearing loss.

  • Costs and consequences of cytomegalovirus disease. Schnitzler, Mark A. // American Journal of Health-System Pharmacy;12/1/2003, Vol. 60 Issue 23, pS5 

    Describes the impact of prophylactic oral ganciclovir therapy on the incidence of cytomegalovirus (CMV) disease. Identification of CMV disease as a cause of morbidity and mortality in solid organ transplant recipients; Observation that CMV disease increases the risk of graft failure which...

  • Ganciclovir/valganciclovir.  // Reactions Weekly;Aug2014, Vol. 1512 Issue 1, p22 

    The article presents a case study of a woman who was admitted to hospital for cough and dyspnoea after being treated for primary cytomegalovirus (CMV) infection by using ganciclovir and valganciclovir drugs.

  • Intravitreal ganciclovir injections in aqueous cytomegalovirus DNA positive hypertensive iritis. Chung, R. S. H.; Chua, C. N. // Eye;Sep2006, Vol. 20 Issue 9, p1080 

    The letter presents a medical case of treating patients suffering from cytomegalovirus DNA positive hypertensive iritis with intravitreal ganciclovir injections. The case of a 42-year-old presented with eye redness and pain is presented. The reccurence of symptoms is said to have initiated for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics